South African Honey: Anti-Helicobacter pylori Activity and Combined Effect With the Gut Microbiome
Sarhana Dinat1, Ané Orchard1, Mike Allsopp2
1Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, wits.ac.za.
Abstract:
Honey has been revered for its medicinal properties for thousands of years, with medicinal uses including treating inflammation and gastric ulcers. The gut pathogen Helicobacter pylori is known to cause inflammation and gastric ulcers. Current treatment options for infection with H. pylori present several concerns due to the rapid gain in resistance and dysbiosis caused to the gut microbiome. While the anti-H. pylori properties of honey have been studied globally, a comprehensive range of southern African honeys has yet to be explored against this pathogen. This study is aimed at investigating South African honey for its anti-H. pylori activity and interaction with gut microbiome species. A total of 76 raw honey samples derived from South African apiarists were investigated, along with Manuka honey included for comparison. The anti-H. pylori activity and interaction with the gut microbiome species were assessed using the minimum inhibitory concentration (MIC) agar dilution assay. The hydrogen peroxide (H2O2) concentration of antimicrobially active samples was determined using colorimetric test strips. A third of the investigated honeys showed activity comparable with that of Manuka honey. Honey derived from fynbos, citrus, coriander, and buchu floral sources demonstrated the best anti-H. pylori activity (MIC of 6.25%). An increase in anti-H. pylori activity was observed for up to 82.50% of combinations of honey and Lactobacillus/Lacticaseibacillus species. A positive correlation (R2 = 0.76) between increased anti-H. pylori activity and increased H2O2 concentrations was observed. These results demonstrate not only the potential of South African honey as anti-H. pylori agents, but also the importance of their interactions with the gut microbiome to enhance inhibition of this ulcer-causing pathogen.
More Related Videos
03:33Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
Published on: May 23, 2025
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Gastritis II: Pathophysiology
Microbiota of the Stomach and Small Intestine
Microbiota Modulation by Antibiotics
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
What is Monogastric Digestion?
